Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Benlasfer, Nouhad (1) Paul, Friedemann Prof. Dr. med. (1) Saar, Kathrin Dr. (1) Willnow, Thomas Prof. Dr. (1) Zenkner, Martina (1) (-) Morano, Ingo Prof. Dr. (1) (-) Wanker, Erich Prof. Dr. (18) AG Müller/Dechend (ECRC) (1) Angeborene Immunität & Neuroinflammation (3) Biobank (2) Experimentelle Ultrahochfeld-MR (2) Genetik und Genomik von Herz- Kreislauferkrankungen (3) Hochschulambulanz für Neuroimmunologie (4) Hypertonie-vermittelter Endorganschaden (1) Hypertonie bedingte Endorganschäden (1) Kardiale MRT (3) Magnetic Resonance (2) Mobile DNA (1) Molekularbiologie von Hormonen im Herz-Kreislaufssystem (36) Molekulare Epidemiologie (2) (-) Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen (19) Psychoneuroimmunologie (1) Synaptische Transmission und Plastitzität (12) Zelluläre Neurowissenschaften (1) 1991 (1) 1995 (4) 1997 (4) 1998 (7) (-) 1999 (8) 2000 (5) 2001 (6) 2002 (5) 2003 (6) 2004 (7) 2005 (8) 2006 (13) 2007 (6) 2008 (6) 2009 (6) 2010 (4) 2011 (6) 2012 (10) (-) 2013 (11) 2014 (9) 2015 (8) 2016 (10) 2017 (6) 2018 (10) 2019 (6) 2020 (10) 2021 (6) 2022 (3) 2023 (5) 2024 (3) 19 Ergebnisse: Active Filter: Morano, Ingo Prof. Dr.Wanker, Erich Prof. Dr.Proteomforschung und molekulare Mechanismen bei neurodegenerativen Erkrankungen19992013 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Februar 2013 / Nucleic Acids Res Development and application of a DNA microarray-based yeast two-hybrid system B. Suter J.F. Fontaine R. Yildirimman T. Raskó M.H. Schaefer A. Rasche P. Porras B.M. Vázquez-Álvarez J. Russ K. Rau R. Foulle M. Zenkner K. Saar R. Herwig M.A. Andrade-Navarro E.E. Wanker 18. Februar 2013 / EPMA J Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases A. Mähler S. Mandel M. Lorenz U. Ruegg E.E. Wanker M. Boschmann F. Paul 26. Februar 2013 / Nat Commun Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex S. Krauss N. Griesche E. Jastrzebska C. Chen D. Rutschow C. Achmüller S. Dorn S.M. Boesch M. Lalowski E. Wanker R. Schneider S. Schweiger 01. April 2013 / Nat Methods A Y2H-seq approach defines the human protein methyltransferase interactome M. Weimann A. Grossmann J. Woodsmith Z. Özkan P. Birth D. Meierhofer N. Benlasfer T. Valovka B. Timmermann E.E. Wanker S. Sauer U. Stelzl 01. Juni 2013 / BioEssays Aggregation of polyQ-extended proteins is promoted by interaction with their natural coiled-coil partners S. Petrakis M.H. Schaefer E.E. Wanker M.A. Andrade-Navarro 01. März 2013 / PLoS Genet Dynamic circadian protein-protein interaction networks predict temporal organization of cellular functions T Wallach K Schellenberg B Maier R.K. Kalathur P. Porras E.E. Wanker M.E. Futschik A. Kramer 01. Januar 2013 / Nat Commun A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases K. Fujita Y. Nakamura T. Oka H. Ito T. Tamura K. Tagawa T. Sasabe A. Katsuta K. Motoki H. Shiwaku M. Sone C. Yoshida M. Katsuno Y. Eishi M. Murata J.P. Taylor E.E. Wanker K. Kono S. Tashiro G. Sobue A.R. La Spada H. Okazawa 25. Juli 2013 / Cell Rep SUMO-2 and PIAS1 modulate insoluble mutant Huntingtin protein accumulation J.G. O'Rourke J.R. Gareau J. Ochaba W. Song T. Raskó D. Reverter J. Lee A.M. Monteys J. Pallos L. Mee M. Vashishtha B.L. Apostol T.P. Nicholson K. Illes Y.Z. Zhu M. Dasso G.P. Bates M. Difiglia B. Davidson E.E. Wanker J.L. Marsh C.D. Lima J.S. Steffan L.M. Thompson 12. Februar 2013 / Amyloid Fibrils and Prefibrillar Aggregates: Molecular and Biological Properties Inhibitors of amyloid and oligomer formation N. Lorenzen E.E. Wanker D. Otzen 01. November 2013 / PLoS Biol HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration M. Mielcarek C. Landles A. Weiss A. Bradaia T. Seredenina L. Inuabasi G.F. Osborne K. Wadel C. Touller R. Butler J. Robertson S.A. Franklin D.L. Smith L. Park P.A. Marks E.E. Wanker E.N. Olson R. Luthi-Carter H. van der Putten V. Beaumont G.P. Bates Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Februar 2013 / Nucleic Acids Res Development and application of a DNA microarray-based yeast two-hybrid system B. Suter J.F. Fontaine R. Yildirimman T. Raskó M.H. Schaefer A. Rasche P. Porras B.M. Vázquez-Álvarez J. Russ K. Rau R. Foulle M. Zenkner K. Saar R. Herwig M.A. Andrade-Navarro E.E. Wanker
18. Februar 2013 / EPMA J Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases A. Mähler S. Mandel M. Lorenz U. Ruegg E.E. Wanker M. Boschmann F. Paul
26. Februar 2013 / Nat Commun Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex S. Krauss N. Griesche E. Jastrzebska C. Chen D. Rutschow C. Achmüller S. Dorn S.M. Boesch M. Lalowski E. Wanker R. Schneider S. Schweiger
01. April 2013 / Nat Methods A Y2H-seq approach defines the human protein methyltransferase interactome M. Weimann A. Grossmann J. Woodsmith Z. Özkan P. Birth D. Meierhofer N. Benlasfer T. Valovka B. Timmermann E.E. Wanker S. Sauer U. Stelzl
01. Juni 2013 / BioEssays Aggregation of polyQ-extended proteins is promoted by interaction with their natural coiled-coil partners S. Petrakis M.H. Schaefer E.E. Wanker M.A. Andrade-Navarro
01. März 2013 / PLoS Genet Dynamic circadian protein-protein interaction networks predict temporal organization of cellular functions T Wallach K Schellenberg B Maier R.K. Kalathur P. Porras E.E. Wanker M.E. Futschik A. Kramer
01. Januar 2013 / Nat Commun A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases K. Fujita Y. Nakamura T. Oka H. Ito T. Tamura K. Tagawa T. Sasabe A. Katsuta K. Motoki H. Shiwaku M. Sone C. Yoshida M. Katsuno Y. Eishi M. Murata J.P. Taylor E.E. Wanker K. Kono S. Tashiro G. Sobue A.R. La Spada H. Okazawa
25. Juli 2013 / Cell Rep SUMO-2 and PIAS1 modulate insoluble mutant Huntingtin protein accumulation J.G. O'Rourke J.R. Gareau J. Ochaba W. Song T. Raskó D. Reverter J. Lee A.M. Monteys J. Pallos L. Mee M. Vashishtha B.L. Apostol T.P. Nicholson K. Illes Y.Z. Zhu M. Dasso G.P. Bates M. Difiglia B. Davidson E.E. Wanker J.L. Marsh C.D. Lima J.S. Steffan L.M. Thompson
12. Februar 2013 / Amyloid Fibrils and Prefibrillar Aggregates: Molecular and Biological Properties Inhibitors of amyloid and oligomer formation N. Lorenzen E.E. Wanker D. Otzen
01. November 2013 / PLoS Biol HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration M. Mielcarek C. Landles A. Weiss A. Bradaia T. Seredenina L. Inuabasi G.F. Osborne K. Wadel C. Touller R. Butler J. Robertson S.A. Franklin D.L. Smith L. Park P.A. Marks E.E. Wanker E.N. Olson R. Luthi-Carter H. van der Putten V. Beaumont G.P. Bates